15 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/akeso-announces-first-patient-dose-in-global-registrational-trial-of-cadonilimab-pd-1ctla-4-for-pd-1-treatment-resistant-hepatocellular-carcinoma-302555984.html
02 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/immuneoncia-announces-interim-results-from-phase-1b-clinical-trial-of-next-generation-cd47-antibody-imc-002-at-asco-2025-302470514.html
25 Jan 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/merck-eisai-star-crossed-keytruda-lenvima-combo-misses-survival-goal-gi-cancer-trial
14 Sep 2024
// BUSINESSWIRE
12 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/medivir-to-present-mature-clinical-data-for-fostrox--lenvima-at-esmo-conference-and-to-host-a-webcast-on-september-16-302246468.html
08 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-esmo-european-society-for-medical-oncology-annual-meeting-302241213.html